We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» German Rivera
German Rivera
Products
PRODUCTS
Galephar Pharmaceutical Research, Inc.
Ariel Cruz Figueroa
and
German Rivera
Price:
$117.00
View
Baxter Healthcare Corp.
Laiza V. Garcia
and
German Rivera
Price:
$117.00
View
Axium Healthcare Pharmacy dba Balanced Solutions Compounding
Thomas E. Friel
,
Brian D. Nicholson
, and
German Rivera
Price:
$117.00
View
Non-Invasive Monitoring Systems, Inc.
German Rivera
and
Karen M. Rodriguez
Price:
$117.00
View
SEI Pharmaceuticals, Inc.
Rachel. A. Peters
and
German Rivera
Price:
$117.00
View
Tarmac Products, Inc. dba Axara Pharmaceuticals
Ileana Barreto-Pettit
,
Gabriel E. Muniz
,
Teresa I. Navas
, and
German Rivera
Price:
$117.00
View
Robaina R. Manufacturing, Inc.
German Rivera
Price:
$117.00
View
Upcoming Events
13
Jul
FDA Ad and Promo Enforcement Trends: Past, Present and Future
27
Jul
Applying the Lessons of the Pandemic to Your Upcoming Trial
28
Jul
EU-MDR’s Growing Pains: Are You Current with the Latest Developments?
28
Jul
Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does
02
Aug
Medical Device Cybersecurity: Understand the Latest Developments
03
Aug
Pharmaceutical Process Validation: Best Practices for Success
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
FX Receives FDA Clearance for Its FX V135 Shoulder Arthroplasty Platform
FDA Recommends Modified COVID-19 Vaccine Boosters Adapted to Omicron BA.4 and BA.5 Subvariants
FDA Approves Foundation Medicine’s Companion Diagnostic for Genentech’s Rozlytrek
Novartis Pays $100 Million for Mallinckrodt’s Priority Review Voucher
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
